The cost of community research-recruiting community-dwelling participants to a feasibility primary care cluster randomised controlled trial.


Journal

Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253

Informations de publication

Date de publication:
08 May 2021
Historique:
received: 02 07 2020
accepted: 26 04 2021
entrez: 9 5 2021
pubmed: 10 5 2021
medline: 22 6 2021
Statut: epublish

Résumé

To support a robust evidence base for the organisation and provision of community-delivered health services for older people, clinical trials need to be designed to account for community-based participant recruitment. There is currently little reported information available on the time and cost of recruiting community-dwelling older people, which makes the completion of cost attribution documentation problematic when applying for research funding. We aimed to establish the amount of researcher time it takes to recruit community-dwelling older people to a feasibility primary care cluster randomised controlled trial, including collecting baseline data. The trial was part of a programme of work investigating an intervention to improve the quality of life for older people with frailty. Two researchers conducting home visits to recruit and collect baseline data from participants recorded the time spent on travelling to and from the visit, at the visit itself and any associated administration. The median total researcher activity time per visit was 148 min. We discuss the various elements of recruitment and data collection activity and the factors that impacted the length of time taken, including location, individuals' capacity and cognition, hearing and visual impairment and the desire for social contact. Studies cannot reach their recruitment targets if they are unrealistically planned and resourced. We recommend that trials recruiting older people in the community allocate two and a half hours of researcher time per person, on average, for consent, baseline data collection, travel and administration. We acknowledge that a variety of different factors will mean that researcher activity will vary between different community-based trials. Our findings give a good starting point for timing calculations, and evidence on which to base the justification of research activity costings. Personalised care planning for older people with frailty ISRCTN12363970 . 08/11/2018.

Sections du résumé

BACKGROUND BACKGROUND
To support a robust evidence base for the organisation and provision of community-delivered health services for older people, clinical trials need to be designed to account for community-based participant recruitment. There is currently little reported information available on the time and cost of recruiting community-dwelling older people, which makes the completion of cost attribution documentation problematic when applying for research funding.
MAIN BODY METHODS
We aimed to establish the amount of researcher time it takes to recruit community-dwelling older people to a feasibility primary care cluster randomised controlled trial, including collecting baseline data. The trial was part of a programme of work investigating an intervention to improve the quality of life for older people with frailty. Two researchers conducting home visits to recruit and collect baseline data from participants recorded the time spent on travelling to and from the visit, at the visit itself and any associated administration. The median total researcher activity time per visit was 148 min. We discuss the various elements of recruitment and data collection activity and the factors that impacted the length of time taken, including location, individuals' capacity and cognition, hearing and visual impairment and the desire for social contact.
CONCLUSION CONCLUSIONS
Studies cannot reach their recruitment targets if they are unrealistically planned and resourced. We recommend that trials recruiting older people in the community allocate two and a half hours of researcher time per person, on average, for consent, baseline data collection, travel and administration. We acknowledge that a variety of different factors will mean that researcher activity will vary between different community-based trials. Our findings give a good starting point for timing calculations, and evidence on which to base the justification of research activity costings.
TRIAL REGISTRATION BACKGROUND
Personalised care planning for older people with frailty ISRCTN12363970 . 08/11/2018.

Identifiants

pubmed: 33964964
doi: 10.1186/s13063-021-05297-3
pii: 10.1186/s13063-021-05297-3
pmc: PMC8106218
doi:

Types de publication

Letter Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

332

Subventions

Organisme : Programme Grants for Applied Research
ID : RP-PG-0216-20003

Références

Trials. 2015 Feb 12;16:1
pubmed: 25971836
Emerg Nurse. 2015 Nov;23(7):26, 28-30
pubmed: 26542924
Pilot Feasibility Stud. 2020 Apr 28;6:56
pubmed: 32355566
BMJ Open. 2017 Mar 20;7(3):e015276
pubmed: 28320800
BMC Geriatr. 2010 Sep 17;10:64
pubmed: 20849598
BMC Med Res Methodol. 2010 Feb 22;10:17
pubmed: 20175903
Age Ageing. 2011 Nov;40(6):659-65
pubmed: 21911335
Trials. 2018 Feb 20;19(1):121
pubmed: 29458392
Br J Community Nurs. 2020 Mar 2;25(3):110-113
pubmed: 32160030
Trials. 2019 Aug 5;20(1):474
pubmed: 31382999
Cochrane Database Syst Rev. 2018 Feb 22;2:MR000013
pubmed: 29468635
Trials. 2013 Jun 09;14:166
pubmed: 23758961

Auteurs

Nicola Harrison (N)

Bradford Institute for Health Research, Bradford Teaching Hospitals NHS Foundation Trust, Bradford, UK.

Caroline Brundle (C)

Bradford Institute for Health Research, Bradford Teaching Hospitals NHS Foundation Trust, Bradford, UK. caroline.brundle@bthft.nhs.uk.

Anne Heaven (A)

Bradford Institute for Health Research, Bradford Teaching Hospitals NHS Foundation Trust, Bradford, UK.

Andrew Clegg (A)

Bradford Institute for Health Research, Bradford Teaching Hospitals NHS Foundation Trust, Bradford, UK.
Academic Unit of Ageing and Stroke Research, University of Leeds, Leeds, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH